Hillsdale Investment Management Inc. / CRC
Hillsdale Investment Management Inc.’s Canadian Nat Res Ltd Med Ter Position
Does Hillsdale Investment Management Inc. own Canadian Nat Res Ltd Med Ter (CRC)? Yes — 775.6K shares worth $38M (+1.03% of its 13F portfolio) as of Q1 2026, up from 488.3K shares the prior filed quarter.
Position Value
$38M
Q1 2026
Shares
775.6K
% of Portfolio
+1.03%
Quarters Held
30
currently held
Position History CRC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 775.6K | $38M | +1.03% |
| Q4 2025 | 488.3K | $17M | +0.46% |
| Q3 2025 | 436.9K | $14M | +0.42% |
| Q2 2025 | 666.4K | $21M | +0.77% |
| Q1 2025 | 396.5K | $12M | +0.62% |
| Q4 2024 | 395.8K | $12M | +0.62% |
| Q3 2024 | 156.6K | $5M | +0.40% |
| Q2 2024 | 324.9K | $12M | +0.91% |
| Q1 2024 | 170.5K | $13M | +1.03% |
| Q4 2023 | 135.3K | $9M | +0.72% |
| Q3 2023 | 84.0K | $5M | +0.50% |
| Q2 2023 | 87.5K | $5M | +0.45% |
| Q1 2023 | 238.4K | $13M | +1.13% |
| Q4 2022 | 494.5K | $27M | +2.32% |
| Q3 2022 | 501.1K | $23M | +2.10% |
| Q2 2022 | 522.2K | $28M | +2.25% |
| Q1 2022 | 592.7K | $37M | +2.37% |
| Q4 2021 | 724.6K | $31M | +2.06% |
| Q3 2021 | 615.6K | $22M | +1.74% |
| Q2 2021 | 349.7K | $13M | +1.01% |
| Q1 2021 | 339.1K | $10M | +0.88% |
| Q4 2020 | 12.9K | $309,000 | +0.03% |
| Q3 2020 | 28.3K | $453,000 | +0.04% |
| Q2 2020 | 551.3K | $10M | +0.87% |
| Q1 2020 | 491.4K | $7M | +0.81% |
| Q4 2019 | 459.5K | $15M | +1.29% |
| Q3 2019 | 487.3K | $13M | +1.13% |
| Q2 2019 | 662.4K | $18M | +1.77% |
| Q1 2019 | 343.3K | $9M | +0.86% |
| Q4 2018 | 388.6K | $9M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hillsdale Investment Management Inc.’s full portfolio or all institutional holders of CRC.